BioSpace News Archive

Promising research from Exact Sciences Corp. and Mayo Clinic shows new methylation and protein markers detect colorectal cancer and advanced adenomas with high accuracy.

Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenue of $218.8 million and screened approximately 456,000 people with Cologuard during the quarter ended September 30, 2019

Cigna Corporation announced that Kimberly A. Ross has been appointed to Cigna’s Board of Directors.

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, announced that it will report its third quarter 2019 financial and operating results after the close of U.S. financial markets on Tuesday, November 5, 2019.

Geisinger announced the release of a study about “variable expressivity,” or how the severity of symptoms caused by a genetic disorder varies from individual to individual, in 11 rare diseases.

The U.S. Food and Drug Administration is taking steps towards requiring electronic submission of certain safety reports for products being evaluated by the FDA under an investigational new drug application into the FDA’s Adverse Event Reporting System The planned process for submissions is outlined in a new draft guidance, and the FDA is also making available supporting technical specification documents.

Progyny, Inc. announced the closing of its initial public offering of 11,500,000 shares of its common stock, including the full exercise by the underwriters of their option to purchase 1,500,000 additional shares of common stock, at a price to the public of $13.00 per share.

Tech Start-up Commercializing Molecular Delivery Technology Discovered by a Nobel Laureate

Three new CVS Pharmacy stores to open in the Portland area by end of 2019, bringing a health-centric retail pharmacy experience to the market

New center of excellence aims to improve rates of cervical cancer screening, tobacco cessation